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Clinical, Hormonal and Genetics Features of Patients with Androgen Insensitivity Syndrome in Semarang
Alvin Tonang1, Sultana MH Faradz2
Abstract
Androgen insensitivity syndrome (AIS) is an X-linked disorder caused by impaired Androgen Receptor
(AR) which is  encoded in Xq 11-12. In this condition, although the androgen is  produced sufficiently,  but  the
peripheral  masculinizing  effect  is  blocked,  therefore  sexual  ambiguity  occurred.  Lack  of  information  and
knowledge of both medical personnel and community made AIS frequently misdiagnose and mismanagement.
This  was  a  descriptive  retrospective  and  prospective  study following the  clinical,  hormonal,  cytogenetic,
and  molecular  study  from  subjects  with  suspected  AIS  from  the  molecular  and  cytogenetic  laboratories  in
Semarang during April 2004 to April 2005. Medical record was obtained from Molecular and Cytogenetic Unit
in Medical Faculty of Diponegoro University and Cytogenetic Laboratory of Telogorejo Hospital.
Quigley stage measurement in 46 PAIS cases were found  in stage 3 for 18 (39,1%); in stage 2 for 16 cases
(34,8%); in stage 4 for 6 cases (13%); in stage 6 for 3 cases (6,5%); in stage 1 for 2 cases (4,3%) and in stage 5
for  1  case  (2,2%).  Twelve  individuals  were  raised  as  female  whose  2  of  them  had  been  operated  for  gender
adjustment to male. There were two large families with familial PAIS suggested an X-linked inheritance. Eight
subjects (16,33%) showed the characteristic of PAIS hormone. Four out of nine subjects who had been examined
using molecular analysis showed missense mutation R840H and I603N.
The diagnosis of PAIS need a complex assessment, not only based on physical examination but also should
be  considered  using  hormonal,  cytogenetic  and  molecular  analysis.  The  majority  of  patients  came  from  low
socioeconomic background, expensive cost and the availability of hormonal and molecular analysis in Indonesia
is the main constraint in establishing the diagnosis. 
Keywords : Androgen Insensitivity Syndrome, clinical features, hormones, AR-gene mutations. 
Gambaran Klinis, Hormon dan Genetik pada Pasien dengan Androgen Insensitivity Syndrome di
Semarang
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Abstrak
Sindrom androgen insensitif (AIS) merupakan kelainan X-link disebabkan karena terganggunya androgen
reseptor (AR) yang dikode di Xq 11-12. Pada kondisi ini, meskipun produksi androgen mencukupi namun efek
maskulinisasi perifer terhambat, dan berakibat pada ambiguitas seksual. Kurangnya informasi dan pengetahuan
kalangan medis dan masyarakat tentang AIS sering mengakibatkan salah diagnosis dan salah manajemen.
Penelitian  ini  merupakan  penelitian  deskriptif  retrospektif  dan  prospektif  tentang  gambaran  klinik,
hormon, sitogenetika, dan molekuler dari subyek dengan suspek AIS di laboratorium molekuler dan sitogenetika
di Semarang dari April 2004 sampai April 2005. Data catatan rekam medik diperoleh dari Unit Molekuler dan
Sitogenetika Fakultas Kedokteran Universitas Diponegoro dan Laboratorium Sitogenetika RS Telogorejo.
Pemeriksaan Quigley pada 46 kasus partial AIS (PAIS) menunjukkan 18 dengan stadium 3 (39,1%); 16
kasus stadium 2 (34,8%); 6 kasus stadium 4 (13%); 3 kasus stadium 6 (6,5%); 2 kasus stadium 1 (4,3%) dan 1
stadium 5 (2,2%). Duabelas individu dibesarkan sebagai perempuan, dan dua diantaranya dioperasi penyesuaian
gender  menjadi  laki-laki.  Terdapat  dua  keluarga  besar  dengan  kecurigaan  PAIS  familial.  Delapan  kasus
(16,33%)  menunjukkan  karakteristik  hormon  penderita  PAIS.  Empat  dari  sembilan  subyek  yang  diperiksa
menunjukkan mutasi missense R840H dan I603N.
Mendiagnosa  PAIS dibutuhkan  suatu  pemeriksaan  yang  komplek,  tidak  hanya  pemeriksaan  fisik  tetapi
juga  dapat  dipertimbangkan  pemeriksaan  hormon,  sitogenetik  dan  analisa  molekuler.  Mayoritas  pasien  datang
dari  latar belakang sosial  ekonomi yang lemah,  mahalnya biaya dan terbatasnya fasilitas  pemeriksan hormonal
dan molekuler merupakan masalah utama dalam penegakkan diagnosis. 
Kata kunci: Sindrom androgen insensitif, gambaran klinik, hormon, mutasi gen-AR.
INTRODUCTION
Sex differentiation and determination is a complex process. It follows a logical cascade, starts from the
chromosomal  sex  determines  the  gonadal  sex  which  is  determines  the  phenotypic  sex1.  In  male  sexual
determination,  Y chromosome especially SRY gene plays important role in changing the gonad into testis  and
the testis will produce hormones for determining male phenotypic sex. 
One of the important hormones in male sexual differentiation is androgen. It is a steroid hormone which
is  synthesized  from  cholesterol.  The  two  most  important  androgens  are  testosterone  and  dihydrotestosterone
(DHT), which the latter is more potent2. In order to work properly, androgen hormones need a receptor, called
androgen receptor  (AR).  Androgen receptor  encoded by the AR-gene,  which  is  located  in  the  long arm of  the
X-chromosome, Xq 11-123,4. Adequate androgen secretion as well as expression of a normal androgen receptor
is important for normal male sexual differentiation and secondary sexual characteristic2,3. 
Androgen Insensitvity Syndrome (AIS) is an X-linked disorder of absent or defect virilization in 46, XY
individuals due to the mutation of AR gene3. In this condition, although the androgen is produced sufficiently,
but  the  peripheral  masculinizing  effect  is  blocked5,6.  The  mutation  can  be  caused  either  by  inheritance  or  by
spontaneous mutation. Most of the cases (70%), AR mutations are transmitted in an X-linked recessive manner
through the carrier mothers, but the remaining mutations (30%) arises de novo7.
There are two types of AIS, complete and partial type8,9.  Patients with partial AIS (PAIS) cause a wide
spectrum  of  phenotype,  ranging  from  mildly  virilized  female  external  genitalia  to  mildly  undervirilized  male
external  genitalia10.  Individuals  with  complete  AIS  (CAIS)  will  show  a  complete  female  external  genitalia,
including the breast development at puberty even a female psychosexual orientation8,11,12.
Individuals  with  AIS  will  get  larger  psychological  problems  compare  to  the  medical  morbidity.  This
problem  would  be  bigger  if  they  should  change  their  gender  and  need  adaptation  for  the  changing  of  sexual
orientation. AIS and also the other sexual ambiguity usually ended by surgery. It is maybe the only way to solve
their conflict by having their known gender. Reconstructive surgery such as vaginoplasty can be done for CAIS,
but  for  PAIS,  sometimes  it  is  hard  to  determine  the  gender  especially  patients  who  come  late.  The  delay  of
seeking medical treatment is  caused by the lack of awareness from the patients,  parents,  and even the medical
society. 
Until now, the incedence of AIS in Indonesia is still unknown. A recent survey done in the Netherlands
over  a  ten  year  period,  from  1984-1993,  based  on  reported  cases  of  AIS  indicated  a  minimal  incidence  of
1:99.0003. From the BBC health reports that in UK at least 1 from 24.600 babies are born with AIS.
There is  a Sexual adjustment team in Dr.  Kariadi university hospital  and working group on ambiguous
genitalia  in  Medical  Faculty  Diponegoro  University.  Most  ambiguous  genitalia  cases  from  other  hospitals  in
central Java are usually referred to this hospital. All members of this multidisciplinary gender team are working
together  to  manage  all  ambiguous  genitalia  (intersexual)  cases.  All  cases  from each  department  (usually  from
Urology,  Pediatric  and  Obstetric-  Gynecology  department)  are  always  sent  to  the  molecular  and  cytogenetic
laboratories  for  chromosome  and  hormonal  analysis  before  being  discussed  by  the  gender  team  There  are  2
cytogenetic  labotories  in  Semarang  namely  Molecular  and  Cytogenetic  Laboratory  of  Medical  Faculty
Diponegoro University and Cytogenetic Laboratory of Telogorejo hospital which is in linked each other. 
The aim of this research is to show the frequency of AIS patients, as well as the hormonal profile, variant
of  phenotypes and also the mutation in  Indonesian people.  It  can provide  advantages  not  only  for  the  medical
society, but also as information for parents and communities. The research for this disorder in Indonesia is scanty
consequently extended research for AIS should be continued to get more accurate data. 
SUBJECT AND METHODS
Subjects
Subjects  for  this  research  are  all  ambiguous  genitalia  patients  sent  to  two  cytogenetic  laboratories  in
Semarang. Target populations are all AIS patient clinically and hormonally diagnosed. This research was using a
secondary data from medical records of AIS patients during period of April 2004- April 2005. Data was obtained
from physical examination, hormonal assay, cytogenetic and mutation analysis. 
Methods
This was a descriptive-observational retrospective and prospective study research. This research has been
conducted in two places: Cytogenetics and Molecular Unit of Biotechnology Laboratory of Medical Faculty of
Diponegoro University Semarang and Cytogenetics Laboratory of Telogorejo Hospital Semarang. 
Patients  diagnosed  as  AIS,  then  examined  for  further  investigation.  Physical  examination  includes
Quigley  stage,  urethrogenital  swelling,  phallus  length,  localization  meatus  urethrae,  presences  of  secondary
sexual  sign.  Gender  type,  pedigree  and  photograph  on  genitalia  were  also  recorded.  Heparinized  and  EDTA
peripheral blood was drawn for chromosome and DNA studies. Chromosome analysis was done using common
G-banding  technique.  DNA  was  extracted  from  leucocytes  of  EDTA  blood  using  salting  out  method  21.
Subsequent DNA and plasma were sent to Erasmus Medical Centre for hormonal analysis and mutation analysis.
Data  processing  on  physical  measurement  and  result  of  cytogenetic  analysis  was  analyzed  with
descriptive method SSPS 11.0 program. The result of data processing was reported in table and chart
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Figure-1. Distribution of age in patients with partial AIS in Semarang 
(N=46)
From all of 46 cases were Partial AIS (PAIS) with 46, XY. In figure-1, we distribute age of the patient
into  9  classes.  This  was  the  age  when  the  patient  checked  up  for  the  first  time.  The  youngest  was  in  age  2
months, and the oldest was in 42 years old.
Quigley stage  was  used  in  classifying  the  external  genitalia.  Eighteen  cases  came  with  Qugley  stage  3
(39,1%), 16 cases with Quigley stage 2 (34,8%). There were 6 cases (13%) with Quigley stage 4, 3 cases (6,5%)
with Quigley stage 6, 2 cases (4,3%) with Quigley stage 1 and 1 case (2,2%) in stage 5 (see table-1)
At  the  time  of  diagnosis,  the  length  of  phallus  of  prepubertal  subjects,  all  with  male  gender,  ranged
between 1,5 cm and 5,4 cm. Two prepubertal subjects with female gender had phallus length 2 cm and 3,7 cm.
Among subjects examined during puberty, phallus measured ranged between 1,5 cm and 7,1 cm in subjects with
female gender. Among the male gender at puberty, the phallus length ranged between 3 cm and 6,5 cm. In post
pubertal  stage,  phallus  measured  2  cm and 5,9  cm in  two subjects  with  female  gender,  while  in  male  gender,
phallus length was 3,4 cm and 4 cm.
Table-1 Profile of patients with PAIS
No Age(yr) Gender
Hormonal Data Mut
atio
n
Q.S
.LH FSH TSN
1 9 M < N <  2
2 15 M > > >  3
3 12 F N > >  3
4 17
M,
formerl
y F
N > <  2
5 26
M,
formerl
y F
> > > R840H 3
6 16 M > N > R840H 2
7 21 M > > > R840H 2
8 10 M N > N  1
9 13 F > > <  6
10 2 M < < < (-) 2
11 2.5 M < < <  3
12 12 M N N < I603N 5
13 14 F > > < (-) 3
14 8 M N N > (-) 4
15 7 M < < <  3
16 23 F > > < (-) 6
17 2 F N < > (-) 4
18 4m M < N <  2
19 10 M < N <  2
20 4 M < < <  2
21 2 M < N <  1
22 7 M < < <  2
23 2 M < < <  2
No Age(yr)
Ge
nde
r
Hormonal Data Mut
atio
n
Q.S
.LH FSH TSN
24 1 M < < <  4
25 3 M < < <  4
26 7 F N > >  3
27 1.5 M < < <  3
28 14 F > > >  2
29 11 M < N <  3
30 14 M N N >  2
31 5 M < N <  4
32 10 M < N >  3
33 14 M N > >  2
34 10 M < < <  3
35 6m M < N <  3
36 3 M < < <  2
37 23 F > N N  3
38 5.5 M < < <  3
39 42 M > > N  3
40 4 F < < <  4
41 1.5 M < N >  3
42 12 M < N <  2
43 2.5 M < N >  3
44 2.5 M < N >  3
45 4.5 M < < N  2
46 22 F > > <  6
Information : 
LH : Liutenizing Hormone
FSH : Follicle Stimulating Hormone
TSN : Testosterone
Q.S. : Quigley Stage
< : Low er than normal
> : Higher than normal
N : In normal range
Ten individuals were raised as female, and 34 individuals were raised as male, while two individuals had
been operated to adjust the gender from female into male (see table-1). From ten female individuals, there were 5
of  them  which  have  introitus  vaginae.  And  from  those  individuals  with  introitus  vaginae,  there  were  1
individuals which has uterus, but without cervix uteri. 
Breast development was found in four post pubertal subjects. One of them had already removed because
of gender adjustment. Pubic hair development was found in 13 subjects.
All  of  those  patients  with  partial  AIS  had  been  taken  their  bloodsample  to  analyze  hormones.  The
interpretation of the hormonal data can be seen in table-1. The interpretation includes of 3 hormones, LH, FSH,
and testosterone.  From the hormonal data,  the hallmark of  AIS was the increase of  LH hormone,  and also the
testosterone can be slightly high or  normal3.  Thus,  from 46  cases,  7  of  them were  diagnosed  as  AIS from the
hormonal status.
Beside  the  hormonal  data,  the  DNA  was  analyzed  in  Rotterdam  resulting  4  cases  with  missense
mutations in the AR-gene (see table-1). Subject no. 5, 6, and 7 were one family (see also family-B) and shown
that mutations of R840H occurs. It means that there was a substitution at codon 840 that resulted in substitution
of arginine (R) into Histidine (H). In subject 15, DNA analysis was shown I603N i.e. substitution of Isoleusin (I)
into asparagine (N) on codon 603.
The other DNA analysis had been done also in subject number 10, 13, 14, 16, 17. Mutation analysis did
not result in the identification of a well known mutation of the androgen receptor gene (see table-1). The result
did not  confirm the diagnosis  complete/partial  androgen insensitivity  syndrome,  but  the result  did  not  exclude
this diagnose either, cause it could be a mutation in somewhere else in the AR gene.
There are two large families that suggested the X-linked of AIS. Not all of the family members could be
studied because they live in different places. The pedigree from both families can be seen in figure-2 below.
There were three subjects with partial AIS in family A. Premature ovarian failure (POF) was running in
this  family.  Subject  IV-3  (no  9),  13  years  old,  was  raised  as  female  with  Quigley  stage  6,  with  normal  labia
majora  and  minora  and  blind  end  vagina.  At  the  diagnosis  was  made,  subject  IV-3  was  already  operated  for
inguinal  testes  and   clitoris  adjusment.  Subject  IV-4  (no  8),  10  years  old,  Quigley  stage  1,  had  scrotum  with
testes right and left, phallus measured at 5.4 cm. Their uncle, subject III-11, 33 years old, had a femine habitus
and  already  married  for  6  years,  but  without  a  child.  Subject  III-11  was  not  included  in  the  hormonal  assay
above,  but  the  DNA  analysis  for  AR-gene  was  made  and  there  were  no  mutation  found  on  the  well  known
region,  but  this  result  could  not  exclude  the  diagnosis  probably  there  is  a  mutation  somewhere  along  the
AR-gene.

There  were  four  subjects  from family  B.  Hormonal  data  of  Subject  III-2  (diagnosed  as  PAIS)  was  not
available because of the rejection of the second blood collection.  Subject  III-5 (see figure-3),  age 27,  also had
gyanecomastia, femine habitus with introitus vaginae, but without uterus, phallus length measured at 2,6 cm, and
also had pubic and axillair hair development. Subject III-2 and III- 5 changed their gender after they are getting
adult because of the androgen exposure made their body posture changed to male. The operation was made not
only for the hypospadia but also to change their gender to male. Subject III-8 (no 6) from family B, 17 years old,
diagnosed with Quigley stage II, had scrotum, phallus length was 3,7 cm and had hypospadia scrotalis. Subject
III-9 (no 7), 21 years old, with Quigley stage II, had scrotum bifid, 3,4 cm of phallus length, and had hypospadia
scrotalis. Both subjects showed hair development in pubic and axillair. Mutation R840H found in subject III-5,
III-8 and III-9. 
DISCUSSION
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Figure-4. Total Sexual Ambiguous and Hypospadia Cases
in Cytogenenetic Laboratories in Semarang per Annum
(Oct 1991-April 2005, N=185)
Until  April  2005,  185  cases  of  sexual  ambiguity  and  hypospadia  have  recorded  in  Cytogenetic
Laboratories in Semarang. There were 93 cases (50,27%) from the Telogorejo Hospital and 92 cases (49,73%)
from the dr. Kariadi Hospital. There was a tendency to increase the case in each year (see figure-4) although it
can  not  be  denied  that  there  are  still  many  more  cases  that  beyond  our  reach.  This  can  be  caused  by  better
information  to  medical  and  public  communities  via  symposia,  seminars  and  workshops  that  make  medical
society more aware15. This awareness can prevent the late diagnosis or even misdiagnosis.
It is hard to detect and diagnose PAIS, since the phenotype are varies among the cases. Cases whose were
raised  as  female,  their  external  genitalia  showed  virilization,  while  the  internal  genitalia  showed  regression
because of the presence of AMH (Anti Mullerian Hormon) or MIS (Mullerian Inhibiting Substance). Hypospadia
and  scrotum  bifidum  were  found  in  almost  all  male  cases.  It  proves  that  male  sexual  differentiation  was  not
completed.
There are twelve individuals (26,09%) which are raised as female. Therefore, gender assignment should
be  preceded  by  the  cytogenetic  examination.  Establishing  the  diagnosis  of  PAIS  is  very  important  for  gender
assignment to an infant of ambiguous genitalia16. Gender adjustment was done in very young age in developed
countries, but in this research the gender adjustment was done after they are getting puberty. 
The pubic and axillair hair development were varied. It can be understood because androgen acts on hair
follicle,  especially  in  pubic,  axillair,  chest  and  face.  Otherwise  in  complete  AIS,  where  there  are  no  androgen
actions  in  the  body,  the  absence  or  minimal  pubic  and  axillair  hair  is  a  stronger  sign  of  CAIS4.  However  the
connection between the AR activity and the pubic hair development is still  unclear, it  is suggest that the pubic
hair may develop independently from AR activity17. The descending of the testis, in almost all cases completed.
Even still in some cases, the testis was refractile or can be moveable into inguinal. This indicates an important,
but not absolute, role of androgen in testicular descent.
This study also reveals  two types of  mutation.  In R840H mutation,  the hormonal  profile  of  the subject
showed the characteristic of PAIS. From the literature, R840 is the codon with the greatest number of different
amino acid substitutions in AIS. There are three other types of mutation in this codon, R840G, R840S, R840C18.
Each of these mutations was associated with a very diverse spectrum of phenotypes19. 
Subject  no  12  with  I603N  mutation,  the  LH  level  was  normal  and  testosterone  level  was  low,  but
phenotypically  as  a  male,  indicated  Quigley  stage  5,  had  the  introitus  vagina  and  ended  blindly.  On  the  other
hand, three subjects with R840H mutation showed Quigley stage 2 and 3. Subject with Quigley stage 3 also had
introitus vaginae and femine habits and already been operated to adjust the gender from female into male. Two
remaining subjects  showed phallus  length 3,4  and 3,7 cm, scrotal  hypospadia,  and also pubic  and  axillair  hair
development. This result shows that PAIS displays a large phenotypic variation, and molecular analysis does not
always explain the variance of the phenotype3,20. More research in AIS probably could reveal the pattern and the
connections between genotype and phenotype.
All of the cases  in this study were PAIS. An interesting case were subject  16 who raised as female,  on
physical examination showed complete female external genitalia (Quigley 6), but also showed Adam apple and
low voice. Hormonal study showed LH and FSH increased but the testosterone level was decreased. Molecular
analysis  did  not  show  any  common  mutation.  This  subject  needs  further  discussion  since  the  physical
examination indicated the sign of AIS.
Along with hormonal and clinical findings for the other subjects still need molecular analysis in order to
make accurate  diagnosis.  For  those  patients  with  no  common  mutation  found  does  not  exclude  the  diagnosis,
because the mutation could be in the other region that should be explored.
Physical  examination,  hormonal,  cytogenetic  and  molecular  studies  in  patients  with  PAIS  should  be
undertaken to established accurate diagnosis15. Unfortunately, in Indonesia, molecular diagnostic test is limited
due to the lack of facilities15 and most of the patients come from low economic level, therefore sometimes AIS is
diagnosed only based on cytogenetic and physical examination. Cooperation with other center is very important
in order to diagnose AIS more accurately. Over time, AIS patients either complete or partial have more risk of
malignant degeneration of the testis3,10. Gonad surgery and long life hormonal therapy should be accompanied by
genetic counseling, psychological approach and also support from family for treatment of patients with PAIS.
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